Koonal K. Shah : Citation Profile


Are you Koonal K. Shah?

University of Sheffield (1% share)

9

H index

8

i10 index

295

Citations

RESEARCH PRODUCTION:

22

Articles

27

Papers

RESEARCH ACTIVITY:

   11 years (2009 - 2020). See details.
   Cites by year: 26
   Journals where Koonal K. Shah has often published
   Relations with other researchers
   Recent citing documents: 42.    Total self citations: 29 (8.95 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psh341
   Updated: 2022-11-19    RAS profile: 2022-04-14    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Devlin, Nancy (18)

Feng, Yan (6)

Cubi-Molla, Patricia (3)

Mott, David (3)

Shah, Kalim (2)

Lorgelly, Paula (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Koonal K. Shah.

Is cited by:

Devlin, Nancy (31)

Brouwer, Werner (13)

van Exel, Job (12)

Attema, Arthur (10)

Gerdtham, Ulf-G. (9)

Lancsar, Emily (8)

pinto-prades, jose-luis (8)

Hultkrantz, Lars (7)

Hernandez Alava, Monica (7)

pudney, stephen (7)

Brazier, John (7)

Cites to:

Devlin, Nancy (63)

Tsuchiya, Aki (36)

Parkin, David (17)

Feng, Yan (17)

Lancsar, Emily (16)

Brouwer, Werner (12)

Brazier, John (10)

Richardson, Jeff (9)

Rice, Nigel (7)

Shah, Kalim (6)

pinto-prades, jose-luis (6)

Main data


Where Koonal K. Shah has published?


Journals with more than one article published# docs
The European Journal of Health Economics7
PharmacoEconomics5
Health Economics3
Social Science & Medicine2
Health Policy2
The Patient: Patient-Centered Outcomes Research2

Working Papers Series with more than one paper published# docs
Research Papers / Office of Health Economics18
Consulting Reports / Office of Health Economics8

Recent works citing Koonal K. Shah (2022 and 2021)


YearTitle of citing document
2021Joint modelling of choice and rating data: Theory and examples. (2021). Hess, Stephane. In: Journal of choice modelling. RePEc:eee:eejocm:v:40:y:2021:i:c:s1755534521000373.

Full description at Econpapers || Download paper

2022How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence. (2022). Boes, Stefan ; Wettstein, Dominik J. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:2:p:112-121.

Full description at Econpapers || Download paper

2021Public values and plurality in health priority setting: What to do when people disagree and why we should care about reasons as well as choices. (2021). Donaldson, Cam ; McHugh, Neil ; Mason, Helen ; Baker, Rachel. In: Social Science & Medicine. RePEc:eee:socmed:v:277:y:2021:i:c:s0277953621002240.

Full description at Econpapers || Download paper

2021Willingness to pay for quality and length of life gains in end of life patients of different ages. (2021). van Exel, Job ; Brouwer, Werner ; Reckers-Droog, Vivian. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003191.

Full description at Econpapers || Download paper

2021Mental health spillovers from serious family illness: Doubly robust estimation using EQ-5D-5L population normative data. (2021). Cullinan, John ; Henry, Edward. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003282.

Full description at Econpapers || Download paper

2021Quality of care experience in aged care: An Australia-Wide discrete choice experiment to elicit preference weights. (2021). Khadka, Jyoti ; Milte, Rachel ; Ratcliffe, Julie ; Chen, Gang ; Kaambwa, Billingsley. In: Social Science & Medicine. RePEc:eee:socmed:v:289:y:2021:i:c:s0277953621007723.

Full description at Econpapers || Download paper

2022An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. (2022). Jommi, Claudio ; Roudijk, Bram ; Ciani, Oriana ; Meregaglia, Michela ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:292:y:2022:i:c:s0277953621008510.

Full description at Econpapers || Download paper

2022The QALY at 50: One story many voices. (2022). Clarke, Philip ; Lloyd, Andrew ; Norman, Richard ; Edwards, Rhiannon Tudor ; Bleichrodt, Han ; Tsuchiya, Aki ; Wong, Ruth ; Rivero-Arias, Oliver ; Spencer, Anne. In: Social Science & Medicine. RePEc:eee:socmed:v:296:y:2022:i:c:s0277953621009850.

Full description at Econpapers || Download paper

2022Estimating an anchored utility tariff for the well-being of older people measure (WOOP) for the Netherlands. (2022). van Exel, Job ; Brouwer, Werner ; Hackert, Mariska ; van Krugten, Frederique ; Jonker, Marcel ; Himmler, Sebastian. In: Social Science & Medicine. RePEc:eee:socmed:v:301:y:2022:i:c:s0277953622002076.

Full description at Econpapers || Download paper

2022Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off technique. (2022). Yang, Ya Ling ; Shah, Koonal ; O'Neill, Ciaran ; Meads, David ; Longworth, Louise ; Carlton, Jill ; Bray, Nathan ; Mukuria, Clara ; Rowen, Donna. In: Social Science & Medicine. RePEc:eee:socmed:v:309:y:2022:i:c:s0277953622005330.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2022Entitlements to Continued Life and the Evaluation of Population Health. (2022). Østerdal, Lars Peter ; Moreno-Ternero, Juan. In: Working Papers. RePEc:hhs:cbsnow:2022_009.

Full description at Econpapers || Download paper

2022Entitlements to continued life and the evaluation of population health. (2022). Moreno-Ternero, Juan ; Osterdal, Lars P. In: Working Papers. RePEc:pab:wpaper:22.08.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021EQ-5D-5L Health-State Values for the Mexican Population. (2021). Zamora Talaya, Bernarda ; Devlin, Nancy ; Galindo-Suarez, Rosa-Maria ; Gutierrez-Delgado, Cristina ; Feng, Yan ; Papadimitropoulos, Manny ; Shah, Koonal ; Cruz-Santiago, Cesar. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00658-0.

Full description at Econpapers || Download paper

2021Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality. (2021). Muhlbacher, Axel ; Lee, Todd A ; Kohlmann, Thomas ; Jiang, Ruixuan ; Pickard, Simon A ; Walton, Surrey ; Shaw, James. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:1:d:10.1007_s10198-020-01224-6.

Full description at Econpapers || Download paper

2021Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms. (2021). Longworth, Louise ; Lenny, Andrew ; Bennett, Bryan ; Shah, Koonal K ; Shaw, James W ; Pickard, Simon A ; Oppe, Mark ; Brazier, John E. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:8:d:10.1007_s10198-021-01337-6.

Full description at Econpapers || Download paper

2021Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states. (2021). Attema, Arthur ; Karimi, M ; Reckers-Droog, V T ; Lipman, S A ; Jakubczyk, M. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:9:d:10.1007_s10198-021-01377-y.

Full description at Econpapers || Download paper

2022Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?. (2022). Brouwer, Werner ; Exel, Job ; Himmler, Sebastian. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:1:d:10.1007_s10198-021-01353-6.

Full description at Econpapers || Download paper

2022Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis. (2022). Lennox, Charlotte ; Kirkpatrick, Tim ; Anderson, Rob ; Hunter, Rachael Maree ; Byng, Richard ; Maguire, Mike ; Stirzaker, Alex ; Haddad, Mark ; Shaw, Jenny ; Taylor, Rod S ; Warren, Fiona. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:2:d:10.1007_s10198-021-01360-7.

Full description at Econpapers || Download 2022

The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study. (2022). Persson, Ulf ; Okhuoya, Paul ; Hoxer, Christina ; Gralen, Katarina ; Olofsson, Sara. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:6:d:10.1007_s10198-021-01415-9.

Full description at Econpapers || Download paper

2021Public Preferences for Allocating Ventilators in an Intensive Care Unit: A Discrete Choice Experiment. (2021). Anstey, Matthew ; Meshcheriakova, Elena ; Manipis, Kathleen ; Dickinson, Helen ; Norman, Richard ; Williams, Iestyn ; Robinson, Suzanne. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:3:d:10.1007_s40271-021-00498-z.

Full description at Econpapers || Download paper

2022Evaluating the Consistency of Patient Preference Estimates: Systematic Variation in Survival—Adverse Event Trade-Offs in Patients with Cancer or Cardiovascular Disease. (2022). Marsh, Kevin ; Krucien, Nicolas. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:15:y:2022:i:1:d:10.1007_s40271-021-00513-3.

Full description at Econpapers || Download paper

2021Valuing SF-6Dv2 in Australia Using an International Protocol. (2021). Brazier, John ; Norman, Richard ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01043-4.

Full description at Econpapers || Download paper

2021What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK. (2021). Barker, Richard W ; Rees, Sian ; Buchanan, James ; Morrell, Liz ; Wordsworth, Sarah. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:12:d:10.1007_s40273-021-01067-w.

Full description at Econpapers || Download paper

2021EQ-5D-Y Value Set for Slovenia. (2021). Ogorevc, Marko ; Rupel, Valentina Prevolnik. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-020-00994-4.

Full description at Econpapers || Download paper

2022How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents. (2022). Viney, Rosalie ; Devlin, Nancy ; Dalziel, Kim ; Bailey, Cate ; Cronin, Paula. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-021-01107-5.

Full description at Econpapers || Download paper

2022A Comparison of PROPr and EQ-5D-5L Value Sets. (2022). Devlin, Nancy ; Viney, Rosalie ; Mulhern, Brendan ; Pan, Tianxin ; Hanmer, Janel ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:3:d:10.1007_s40273-021-01109-3.

Full description at Econpapers || Download paper

2022Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review. (2022). Lancsar, Emily ; Devlin, Nancy ; Petrou, Stavros ; Howell, Martin ; Norman, Richard ; Bailey, Cate ; Mulhern, Brendan J ; Huynh, Elisabeth ; Craig, Jonathan C ; Viney, Rosalie ; Coast, Joanna ; Howard, Kirsten ; Chen, Gang ; Street, Deborah J ; Salisbury, Amber ; Ratcliffe, Julie ; Raghunandan, Rakhee. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:7:d:10.1007_s40273-022-01149-3.

Full description at Econpapers || Download 2022

A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets. (2022). McDool, Emily ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:9:d:10.1007_s40273-022-01159-1.

Full description at Econpapers || Download paper

2021Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis. (2021). Goodall, Stephen ; Cook, Greg ; Kim, Hansoo ; Liew, Danny. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-021-00265-8.

Full description at Econpapers || Download paper

2022NICE and the EQ-5D-5L: Ten Years Trouble. (2022). Sampson, Christopher. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:1:d:10.1007_s41669-021-00315-1.

Full description at Econpapers || Download paper

2022Examining the Association between Polish Migrant Status and Health Preferences Using a Novel Application of a Smaller Design EQ-5D-5L Valuation Study. (2022). Baio, Gianluca ; Doherty, Edel ; Kharroubi, Samer ; Kelleher, Dan ; Oneill, Ciaran. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:3:d:10.1007_s41669-021-00314-2.

Full description at Econpapers || Download paper

2021Social tariffs and democratic choice—Do population?based health state values reflect the will of the people?. (2021). Schneider, Paul Peter. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:1:p:104-112.

Full description at Econpapers || Download paper

2021Resource scarcity and prioritization decisions in medical care: A lab experiment with heterogeneous patient types. (2021). Einhaus, Lisa ; Brendel, Franziska ; Then, Franziska. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:2:p:470-477.

Full description at Econpapers || Download paper

2022Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost?effectiveness assessment on health utility for targeted medicines. (2022). Branke, Juergen ; Gokalp, Elvan ; Kimani, Peter ; Stallard, Nigel ; Gallacher, Daniel. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:2:p:417-430.

Full description at Econpapers || Download paper

2022Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis). (2022). Norman, Richard ; Jonker, Marcel F. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:2:p:431-439.

Full description at Econpapers || Download paper

2022Mapping between EQ?5D?3L and EQ?5D?5L: A survey experiment on the validity of multi?instrument data. (2022). Pudney, Stephen ; Hernandezalava, Monica. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:6:p:923-939.

Full description at Econpapers || Download paper

2022Correcting for discounting and loss aversion in composite time trade?off. (2022). Versteegh, Matthijs M ; Attema, Arthur E ; Lipman, Stefan A. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:8:p:1633-1648.

Full description at Econpapers || Download paper

Works by Koonal K. Shah:


YearTitleTypeCited
2011NICEs Social Value Judgements about Equity in Health and Health Care In: Working Papers.
[Full Text][Citation analysis]
paper7
2013NICEs social value judgements about equity in health and health care.(2013) In: Health Economics, Policy and Law.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 7
article
2020Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland In: Health Policy.
[Full Text][Citation analysis]
article1
2009Severity of illness and priority setting in healthcare: A review of the literature In: Health Policy.
[Full Text][Citation analysis]
article47
2015Valuing health at the end of life: A stated preference discrete choice experiment In: Social Science & Medicine.
[Full Text][Citation analysis]
article15
2012Valuing Health at the End of Life: A Stated Preference Discrete Choice Experiment.(2012) In: Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 15
paper
2018Valuing health at the end of life: A review of stated preference studies in the social sciences literature In: Social Science & Medicine.
[Full Text][Citation analysis]
article9
2014The Expanding Value Footprint of Oncology Treatments In: Consulting Reports.
[Full Text][Citation analysis]
paper4
2010The Publicly Funded Vaccines Market in Australia In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2010The Publicly Funded Vaccines Market in the UK In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2009Assessment and Appraisal of Oncology Medicines: NICEs Approach and International HTA Experience In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices? In: Consulting Reports.
[Full Text][Citation analysis]
paper2
2018Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2020Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing? In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2013Exploring the link between health and wealth in decision making In: Research Papers.
[Full Text][Citation analysis]
paper0
2012Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity In: Research Papers.
[Full Text][Citation analysis]
paper2
2011Valuing Health at the End of Life: An Exploratory Preference Elicitation Study In: Research Papers.
[Full Text][Citation analysis]
paper0
2011Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Papers.
[Full Text][Citation analysis]
paper3
2010A Comparison of Alternative Variants of the Lead and Lag Time TTO In: Research Papers.
[Full Text][Citation analysis]
paper18
2013A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 18
article
2010Using QALYs in Cancer: Review of the Methodological Limitations In: Research Papers.
[Full Text][Citation analysis]
paper12
2014Exploring the Interdependencies of Research Funders in the UK In: Research Papers.
[Full Text][Citation analysis]
paper2
2015An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates In: Research Papers.
[Full Text][Citation analysis]
paper1
2016Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England In: Research Papers.
[Full Text][Citation analysis]
paper79
2018Valuing health?related quality of life: An EQ?5D?5L value set for England.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 79
article
2016New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data In: Research Papers.
[Full Text][Citation analysis]
paper17
2018New methods for modelling EQ?5D?5L value sets: An application to English data.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 17
article
2016Important Aspects of Health Not Captured by EQ-5D: Views of the UK General Public In: Research Papers.
[Full Text][Citation analysis]
paper0
2017What is the Normative Basis for Selecting the Measure of Average Preferences for Use in Social Choices? In: Research Papers.
[Full Text][Citation analysis]
paper5
2017Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets In: Research Papers.
[Full Text][Citation analysis]
paper6
2018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.(2018) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 6
article
2017Age and Utilities: Issues for HTA In: Research Papers.
[Full Text][Citation analysis]
paper0
2017A New Valuation Method: Directly Eliciting Personal Utility Functions In: Research Papers.
[Full Text][Citation analysis]
paper1
2019Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? In: Research Papers.
[Full Text][Citation analysis]
paper4
2020Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead In: Research Papers.
[Full Text][Citation analysis]
paper2
2013One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2014Valuing health at the end of life: an empirical study of public preferences In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article15
2018Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article4
2019A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article5
2020Economic evaluation of meningococcal vaccines: considerations for the future In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2020HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2017Views of the UK General Public on Important Aspects of Health Not Captured by EQ-5D In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]
article3
2018Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]
article2
2016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes In: PharmacoEconomics.
[Full Text][Citation analysis]
article14
2018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]
article5
2018Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2020International Valuation Protocol for the EQ-5D-Y-3L In: PharmacoEconomics.
[Full Text][Citation analysis]
article1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 1st 2022. Contact: CitEc Team